KING PHARMACEUTICALS RESEARCH & DEVELOPMENT INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are BARALDI PIER GIOVANNI, LYSOSOMAL THERAPEUTICS INC and BAYER YAKUHIN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Sugars | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Baraldi Pier Giovanni | 5 |
#2 | Chesmore Gerald | 4 |
#3 | Pawlak Dan | 4 |
#4 | Knoll Bradley H | 4 |
#5 | Terrab Abdel Hak | 3 |
#6 | Irwin J Foster | 3 |
#7 | Moorman Allan R | 3 |
#8 | Romagnoli Romeo | 2 |
#9 | Borea Pier A | 2 |
#10 | Borea Pier Andrea | 2 |
Publication | Filing date | Title |
---|---|---|
AU2015203312A1 | Thrombin purification | |
AU2012202847A1 | Thrombin purification | |
AU2008256797A1 | Pharmaceutical compositions for the treatment of pain | |
AU2007237370A1 | Thrombin purification | |
AU2004274475A1 | Novel adenosine A3 receptor agonists | |
AU2002361864A1 | Tyrosyl derivatives and their use as p2x7 receptor modulators |